Margarida Simao-Rafael

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Margarida Simao-Rafael

Jan 19, 2025, 14:02 | Insight

Cristina L.: Anti-GD2 Immunotherapy in retinoblastoma

Cristina L., Specialist doctor at Sant Joan de Déu Hospital Barcelona, shared on LinkedIn: “Anti-GD2…

May 5, 2024, 14:01 | Blog

Maite Gorostegui: Our paper about Management of High-Risk Neuroblastoma in the Era of Anti-GD2 Immunotherapy

Maite Gorostegui, Pediatric Oncologist at Pediatric Cancer Center Barcelona, shared a post on LinkedIn: "We just…

All: 2 Posts: 1 - 100

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

'

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023